Loading...
Eosinophilic Panniculitis Following the Subcutaneous Injection of Exenatide Extended-Release
Exenatide extended-release was recently developed as an antidiabetic drug; it acts as a glucagon-like peptide-1 receptor agonist. A 54-year-old male visited our clinic complaining of a subcutaneous tender nodule on his left thigh that had developed over the course of 1 week. The patient had received...
Saved in:
| Published in: | Ann Dermatol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7992610/ https://ncbi.nlm.nih.gov/pubmed/33911742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2020.32.3.230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|